BSL2-compliant lethal mouse model of SARS-CoV-2 and variants of concern to evaluate therapeutics targeting the Spike protein

Since first reported in 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is rapidly acquiring mutations, particularly in the spike protein, that can modulate pathogenicity, transmission and antibody evasion leading to successive waves of COVID19 infections despite an unprecedented...

Descripción completa

Detalles Bibliográficos
Autores principales: Manangeeswaran, Mohanraj, Ireland, Derek D. C., Thacker, Seth G., Lee, Ha-Na, Kelley-Baker, Logan, Lewkowicz, Aaron P., Rothlauf, Paul W., Cornejo Pontelli, Marjorie, Bloyet, Louis-Marie, Eckhaus, Michael A., Mendoza, Mirian I., Whelan, Sean, Verthelyi, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367692/
https://www.ncbi.nlm.nih.gov/pubmed/35967447
http://dx.doi.org/10.3389/fimmu.2022.919815

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367692/
https://www.ncbi.nlm.nih.gov/pubmed/35967447
http://dx.doi.org/10.3389/fimmu.2022.919815

Ejemplares similares